Serotonin transporter binding increases in caudate-putamen and nucleus accumbens after neonatal 6-hydroxydopamine lesions in rats: Implications for motor hyperactivity

Developmental Brain Research

Volumn 137, Issue 2, 2002, Pages 135-138

  Zhang, Kehong ^a,b   Davids, Eugen ^b   Tarazi, Frank I ^b   Baldessarini, Ross J ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

5 Hydroxytryptamine (5 HT) transporter; 6 Hydroxydopamine; Caudate putamen; Development; Motor hyperactivity; Nucleus accumbens

Indexed keywords

OXIDOPAMINE; SEROTONIN TRANSPORTER;

ADULTHOOD; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BRAIN CORTEX; BRAIN DEVELOPMENT; BRAIN INJURY; CAUDATE NUCLEUS; CONTROLLED STUDY; DEVELOPMENTAL STAGE; HYPERACTIVITY; NEWBORN; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN BINDING; PUTAMEN; QUANTITATIVE ANALYSIS; RAT; TISSUE SPECIFICITY;

AGING; ANIMALS; ANIMALS, NEWBORN; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CARRIER PROTEINS; DISEASE MODELS, ANIMAL; FEMALE; HYPERKINESIS; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; NEOSTRIATUM; NERVE TISSUE PROTEINS; NEURONAL PLASTICITY; NUCLEUS ACCUMBENS; OXIDOPAMINE; PRESYNAPTIC TERMINALS; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SYNAPTIC TRANSMISSION; UP-REGULATION;

EID: 0037199703     PISSN: 01653806     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-3806(02)00436-4     Document Type: Article

References (33)

1. Barkley R.A. Attention Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment. 1990;Guilford Press, New York.
2. Berger T.W., Kaul S., Stricker E.M., Zigmond M.J. Hyperinnervation of the striatum by dorsal raphe afferents after dopamine-depleting brain lesions in neonatal rats. Brain Res. 336:1985;354-358.
3. Breese G.R., Baumeister A., McCown T.J., et al. Neonatal 6-hydroxydopamine treatment: Model of susceptibility for self-mutilation in the Lesch-Nyhan syndrome. Pharmacol. Biochem. Behav. 21:1984;459-461.
4. Davids E., Zhang K., Kula N.S., Tarazi F.I., Baldessarini R.J. Effects of norepinephrine and serotonin transporter inhibitors on hyperactivity induced by neonatal 6-hydroxydopamine lesioning in rats. J. Pharmacol. Exp. Ther. 301:2002;1-6.
5. Descarries L., Soghomonian J.J., Garcia S., Doucet G., Bruno J.P. Ultrastructural analysis of serotonin hyperinnervation in adult rat neostriatum following neonatal dopamine denervation with 6-hydroxy-dopamine. Brain Res. 569:1992;1-13.
6. Descarries L., Soucy J.P., Lafaille F., Mrini A., Tanguay R. Evaluation of three transporter ligands as quantitative markers of serotonin innervation density in rat brain. Synapse. 21:1995;131-139.
7. 1 receptors in adult rat neostriatum after neonatal 6-hydroxydopamine denervation. Brain Res. 536:1990;287-296.
8. Heffner T.G., Seiden L.S. Possible involvement of serotonergic neurons in the reduction of locomotor hyperactivity caused by amphetamine in neonatal rats depleted of brain dopamine. Brain Res. 244:1982;81-90.
9. Gong L., Kostrzewa R.M. Supersentitized oral responses to a serotonin agonist in neonatal 6-OHDA-treated rats. Pharmacol. Biochem. Behav. 41:1992;621-623.
10. Kostrzewa R.M., Brus R., Kalbfleisch J.H., Perry K.W., Fuller R.W. Proposed animal model of attention deficit hyperactivity disorder. Brain Res. Bull. 34:1994;161-167.
11. Kostrzewa R.M. Dopamine receptor supersensitivity. Neurosci. Biobehav. Rev. 19:1995;1-17.
12. 3H]cyanoimipramine. Brain Res. 454:1988;78-88.
13. 3H]β-CIT: a radioligand for dopamine transporter in rat brain tissue. Eur. J. Pharmacol. 385:1999;291-294.
14. Lucot J.B., Seiden L.S. Effects of neonatal administration of 5,7-dihydroxytryptamine on locomotor activity. Psychopharmacology. 77:1982;114-116.
15. Lucot J.B., Seiden L.S. Effects of serotonergic agonists and antagonists on the locomotor activity of neonatal rats. Pharmacol. Biochem. Behav. 24:1986;537-541.
16. Luthman J., Bolioli B., Tsutsumi T., Verhofstad A., Jonsson G. Sprouting of striatal serotonin nerve terminals following selective lesions of nigro-striatal dopamine neurons in neonatal rat. Brain Res. Bull. 19:1987;269-274.
17. Luthman J., Brodin E., Sundstrom E., Wiehager B. Studies on brain monoamine and neuropeptide systems after neonatal intracerebroventricular 6-hydroxydopamine treatment. Int. J. Dev. Neurosci. 8:1990;549-560.
18. Luthman J., Fredriksson A., Lewander T., Jonsson G., Archer T. Effects of d-amphetamine and methylphenidate on hyperactivity produced by neonatal 6-hydroxydopamine treatment. Psychopharmacology. 99:1989;550-557.
19. Miller F.E., Heffner T.G., Kotake C., Seiden L.S. Magnitude and duration of hyperactivity following neonatal 6-hydroxydopamine is related to the extent of brain dopamine depletion. Brain Res. 229:1981;123-132.
20. Molina-Holgado E., Dewar K.M., Descarries L., Reader T.A. Altered dopamine and serotonin metabolism in the dopamine-denevated and serotonin-hyperinnervated neostriatum of adult rat after neonatal 6-hydroxydopamine. J. Pharmacol. Exp. Ther. 270:1994;713-721.
21. Mrini A., Soucy J.P., Lafaille F., Lemoine P., Descarries L. Quantification of the serotonin hyperinnervation in adult rat neostriatum after neonatal 6-hydroxydopamine lesion of nigral dopamine neurons. Brain Res. 669:1995;303-308.
22. Raison S., Weissmann D., Rousset C., Pujol J.F., Descarries L. Changes in steady-state levels of tryptophan hydroxylase in adult rat brain after neonatal 6-hydroxydopamine lesion. Neuroscience. 67:1995;463-475.
23. Shaywitz B.A., Yager R.D., Klopper J.H. Selective brain dopamine depletion in developing rats: An experimental model of minimal brain dysfunction. Science. 191:1976;305-308.
24. Smith R.D., Cooper B.R., Breese G.R. Growth and behavioral changes in developing rats treated intracisternally with 6-hydroxydopamine: Evidence for involvement of brain dopamine. J. Pharmacol. Exp. Ther. 185:1973;609-619.
25. Snyder A.M., Zigmond M.J., Lund R.D. Sprouting of serotonergic afferents into striatum after dopamine-depleting lesions in infant rats: A retrograde transport and immunocytochemical study. J. Comp. Neurol. 245:1986;274-281.
26. Stachowiak M.K., Bruno J.P., Snyder A.M., Stricker E.M., Zigmond M.J. Apparent sprouting of striatal serotonergic terminals after dopamine-depleting brain lesions in neonatal rats. Brain Res. 291:1984;164-167.
27. Takasuna M., Iwasaki T. Active and passive avoidance learning in rats neonatally treated with intraventricular 6-hydroxydopamine. Behav. Brain Res. 74:1996;119-126.
28. Towle A.C., Criswell H.E., Maynard E.H., et al. Serotonergic innervation of the rat caudate following a neonatal 6-hydroxydopamine lesion: An anatomical, biochemical and pharmacological study. Pharmacol. Biochem. Behav. 34:1989;367-374.
29. Ungerstedt U. Adipsia and aphagia after 6-hydroxydopamine-induced degeneration of the nigrostriatal dopamine system. Acta Physiol. Scand. Suppl. 367:1971;95-122.
30. Warbritton J.D., Stewart R.M., Baldessarini R.J. Decreased locomotor activity and attenuation of amphetamine hyperactivity with intraventricular infusion of serotonin in the rat. Brain Res. 143:1978;373-382.
31. Weimuller F.B., Bruno J.P. Drinking behavior and motor function in rat pups depleted of brain dopamine during development. Dev. Psychobiol. 22:1989;101-114.
32. 4 receptors in motor hyperactivity induced by neonatal 6-hydroxydopamine lesions in rats. Neuropsychopharmacology. 25:2001;624-632.
33. 4 receptors in rat forebrain: Temporal association with motor hyperactivity following neonatal 6-hydroxydopamine lesioning. Neuropsychopharmacology. 26:2002;625-633.